158 related articles for article (PubMed ID: 20212477)
1. Oversulfated chondroitin sulfate is not the sole contaminant in heparin.
Pan J; Qian Y; Zhou X; Pazandak A; Frazier SB; Weiser P; Lu H; Zhang L
Nat Biotechnol; 2010 Mar; 28(3):203-7; author reply 207-11. PubMed ID: 20212477
[No Abstract] [Full Text] [Related]
2. Method to detect contaminants in heparin using radical depolymerization and liquid chromatography-mass spectrometry.
Li G; Cai C; Li L; Fu L; Chang Y; Zhang F; Toida T; Xue C; Linhardt RJ
Anal Chem; 2014 Jan; 86(1):326-30. PubMed ID: 24364596
[TBL] [Abstract][Full Text] [Related]
3. Case study: contamination of heparin with oversulfated chondroitin sulfate.
Chess EK; Bairstow S; Donovan S; Havel K; Hu P; Johnson RJ; Lee S; McKee J; Miller R; Moore E; Nordhaus M; Ray J; Szabo C; Wielgos T
Handb Exp Pharmacol; 2012; (207):99-125. PubMed ID: 22566223
[TBL] [Abstract][Full Text] [Related]
4. Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins.
Li B; Suwan J; Martin JG; Zhang F; Zhang Z; Hoppensteadt D; Clark M; Fareed J; Linhardt RJ
Biochem Pharmacol; 2009 Aug; 78(3):292-300. PubMed ID: 19389385
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an ion-exchange chromatography method for heparin and its impurities in heparin products.
Thiangthum S; Vander Heyden Y; Buchberger W; Viaene J; Prutthiwanasan B; Suntornsuk L
J Sep Sci; 2014 Nov; 37(22):3195-204. PubMed ID: 25146711
[TBL] [Abstract][Full Text] [Related]
6. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.
Guerrini M; Beccati D; Shriver Z; Naggi A; Viswanathan K; Bisio A; Capila I; Lansing JC; Guglieri S; Fraser B; Al-Hakim A; Gunay NS; Zhang Z; Robinson L; Buhse L; Nasr M; Woodcock J; Langer R; Venkataraman G; Linhardt RJ; Casu B; Torri G; Sasisekharan R
Nat Biotechnol; 2008 Jun; 26(6):669-75. PubMed ID: 18437154
[TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
[TBL] [Abstract][Full Text] [Related]
8. Electrophoresis for the analysis of heparin purity and quality.
Volpi N; Maccari F; Suwan J; Linhardt RJ
Electrophoresis; 2012 Jun; 33(11):1531-7. PubMed ID: 22736353
[TBL] [Abstract][Full Text] [Related]
9. One-hour screening of adulterated heparin by simplified peroxide digestion and fast RPIP-LC-MS(2).
Li H; Wickramasekara S; Nemes P
Anal Chem; 2015 Aug; 87(16):8424-32. PubMed ID: 26168275
[TBL] [Abstract][Full Text] [Related]
10. Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.
Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
J Pharm Biomed Anal; 2011 Apr; 54(5):1020-9. PubMed ID: 21215547
[TBL] [Abstract][Full Text] [Related]
11. Identification of a simple and sensitive microplate method for the detection of oversulfated chondroitin sulfate in heparin products.
Bairstow S; McKee J; Nordhaus M; Johnson R
Anal Biochem; 2009 May; 388(2):317-21. PubMed ID: 19289093
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and detection of N-sulfonated oversulfated chondroitin sulfate in marketplace heparin.
Mans DJ; Ye H; Dunn JD; Kolinski RE; Long DS; Phatak NL; Ghasriani H; Buhse LF; Kauffman JF; Keire DA
Anal Biochem; 2015 Dec; 490():52-4. PubMed ID: 26278168
[TBL] [Abstract][Full Text] [Related]
13. The tainted heparin story: an update.
Guerrini M; Shriver Z; Bisio A; Naggi A; Casu B; Sasisekharan R; Torri G
Thromb Haemost; 2009 Nov; 102(5):907-11. PubMed ID: 19888527
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin.
Viskov C; Bouley E; Hubert P; Martinez C; Herman F; Jeske W; Hoppensteadt D; Walenga JM; Fareed J
Clin Appl Thromb Hemost; 2009; 15(4):395-401. PubMed ID: 19617248
[TBL] [Abstract][Full Text] [Related]
15. Modulating luminescence of Tb(3+) with biomolecules for sensing heparin and its contaminant OSCS.
Hu Y; Guo W; Ding Y; Cheng H; Wei H
Biosens Bioelectron; 2016 Dec; 86():858-863. PubMed ID: 27494809
[TBL] [Abstract][Full Text] [Related]
16. Structure elucidation and biological activity of the oversulfated chondroitin sulfate contaminant in Baxter heparin.
McKee J; Bairstow S; Szabo C; Ray J; Wielgos T; Hu P; Chess E; Nordhaus M; Hai T; Campbell J; Donovan S; Viseux N; Riedel N; Cammack J; Johnson R
J Clin Pharmacol; 2010 Oct; 50(10):1159-70. PubMed ID: 20147614
[TBL] [Abstract][Full Text] [Related]
17. Source-induced fragmentation of heparin, heparan, and galactosaminoglycans and application.
Hu P; Fang L; Chess EK
Anal Chem; 2009 Mar; 81(6):2332-43. PubMed ID: 19228018
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Taq polymerase as a method for screening heparin for oversulfated contaminants.
Tami C; Puig M; Reepmeyer JC; Ye H; D'Avignon DA; Buhse L; Verthelyi D
Biomaterials; 2008 Dec; 29(36):4808-14. PubMed ID: 18801571
[TBL] [Abstract][Full Text] [Related]
19. Determination of Oversulphated Chondroitin Sulphate and Dermatan Sulphate in unfractionated heparin by (1)H-NMR - Collaborative study for quantification and analytical determination of LoD.
McEwen I; Mulloy B; Hellwig E; Kozerski L; Beyer T; Holzgrabe U; Wanko R; Spieser JM; Rodomonte A
Pharmeuropa Bio; 2008 Dec; 2008(1):31-9. PubMed ID: 19220979
[TBL] [Abstract][Full Text] [Related]
20. Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.
Zang Q; Keire DA; Buhse LF; Wood RD; Mital DP; Haque S; Srinivasan S; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
Anal Bioanal Chem; 2011 Aug; 401(3):939-55. PubMed ID: 21678118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
